SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001718108-21-000030
Filing Date
2021-08-05
Accepted
2021-08-05 07:06:34
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-20210630.htm   iXBRL 10-Q 1215026
2 EX-1.1 surf-06302021xexx11.htm EX-1.1 39696
3 EX-31.1 surf-06302021xexx311.htm EX-31.1 10214
4 EX-31.2 surf-06302021xexx312.htm EX-31.2 10014
5 EX-32.1 surf-06302021xexx321.htm EX-32.1 5148
6 EX-32.2 surf-06302021xexx322.htm EX-32.2 4856
  Complete submission text file 0001718108-21-000030.txt   6150455

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT surf-20210630.xsd EX-101.SCH 42235
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT surf-20210630_cal.xml EX-101.CAL 60057
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT surf-20210630_def.xml EX-101.DEF 247361
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT surf-20210630_lab.xml EX-101.LAB 581433
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT surf-20210630_pre.xml EX-101.PRE 387442
12 EXTRACTED XBRL INSTANCE DOCUMENT surf-20210630_htm.xml XML 897771
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 211146266
SIC: 2836 Biological Products, (No Diagnostic Substances)